The FDA has approved Astellas’ new overactive bladder disorder drug Myrbetriq. Myrbetriq (mirabegron), the first drug in its class, works …
GlaxoSmithKline's urinary treatment Avodart works better as part of a combination therapy, according to a new survey. The drug was …

